dc.contributor.author
Cordes, Magdalena
dc.contributor.author
Bucichowski, Piotr
dc.contributor.author
Alfaar, Ahmad S.
dc.contributor.author
Tsang, Stephen H.
dc.contributor.author
Almedawar, Seba
dc.contributor.author
Reichhart, Nadine
dc.contributor.author
Strauß, Olaf
dc.date.accessioned
2022-03-16T12:26:03Z
dc.date.available
2022-03-16T12:26:03Z
dc.identifier.uri
https://refubium.fu-berlin.de/handle/fub188/34421
dc.identifier.uri
http://dx.doi.org/10.17169/refubium-34139
dc.description.abstract
The BEST1 gene product bestrophin-1, a Ca2+-dependent anion channel, interacts with CaV1.3 Ca2+ channels in the retinal pigment epithelium (RPE). BEST1 mutations lead to Best vitelliform macular dystrophy. A common functional defect of these mutations is reduced trafficking of bestrophin-1 into the plasma membrane. We hypothesized that this defect affects the interaction partner CaV1.3 channel affecting Ca2+ signaling and altered RPE function. Thus, we investigated the protein interaction between CaV1.3 channels and bestrophin-1 by immunoprecipitation, CaV1.3 activity in the presence of mutant bestrophin-1 and intracellular trafficking of the interaction partners in confluent RPE monolayers. We selected four BEST1 mutations, each representing one mutational hotspot of the disease: T6P, F80L, R218C, and F305S. Heterologously expressed L-type channels and mutant bestrophin-1 showed reduced interaction, reduced CaV1.3 channel activity, and changes in surface expression. Transfection of polarized RPE (porcine primary cells, iPSC-RPE) that endogenously express CaV1.3 and wild-type bestrophin-1, with mutant bestrophin-1 confirmed reduction of CaV1.3 surface expression. For the four selected BEST1 mutations, presence of mutant bestrophin-1 led to reduced CaV1.3 activity by modulating pore-function or decreasing surface expression. Reduced CaV1.3 activity might open new ways to understand symptoms of Best vitelliform macular dystrophy such as reduced electro-oculogram, lipofuscin accumulation, and vision impairment.
en
dc.rights.uri
https://creativecommons.org/licenses/by-nc-nd/4.0/
dc.subject
bestrophin-1
en
dc.subject
retinal degeneration
en
dc.subject
surface expression
en
dc.subject.ddc
600 Technik, Medizin, angewandte Wissenschaften::610 Medizin und Gesundheit::610 Medizin und Gesundheit
dc.title
Inhibition of Ca 2+ channel surface expression by mutant bestrophin‐1 in RPE cells
dc.type
Wissenschaftlicher Artikel
dcterms.bibliographicCitation.doi
10.1096/fj.201901202rr
dcterms.bibliographicCitation.journaltitle
The FASEB Journal
dcterms.bibliographicCitation.number
3
dcterms.bibliographicCitation.originalpublishername
Wiley
dcterms.bibliographicCitation.pagestart
4055
dcterms.bibliographicCitation.pageend
4071
dcterms.bibliographicCitation.volume
34
refubium.affiliation
Charité - Universitätsmedizin Berlin
refubium.funding
DEAL Wiley
refubium.resourceType.isindependentpub
no
dcterms.accessRights.openaire
open access
dcterms.bibliographicCitation.pmid
31930599
dcterms.isPartOf.issn
0892-6638
dcterms.isPartOf.eissn
1530-6860